from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0874c/-

LFCtreatmentdescriptionclass of inhibitor

-0.650

Amikacinug/mL Amikacintranslation

-0.819

Cap5-10ug/mL Capreomycintranslation

-0.243

Rox10-50 ug/mL Roxithromycintranslation

-0.768

SM2-5 ug/mL Streptomycintranslation

-0.763

Tet5-10 ug/mL Tetracyclinetranslation

-0.176

Rif0.2-5ug/mL Rifampicintranscription

-0.339

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.043

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.075

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.339

CPZ10-50 ug/mL Chlorpromazinerespiration

0.989

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.341

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.459

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.075

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.675

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.251

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.279

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.986

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.759

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.553

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.077

KCN5-20 ug/mL Potassium cyaniderespiration

0.779

NaN30.2-2 mM Sodium aziderespiration

-0.119

Nigericin50 uM Nigericinrespiration

1.294

TRC10-150 ug/mL Triclosanrespiration

1.921

TRZ10-25 ug/mL Thioridazinerespiration

-0.391

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.080

menadione6-10 ug/mL Menadionerespiration

-0.306

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.576

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.467

NRP_1Non-replicating persistence stage 1dosRassociated

-0.448

Amp0.2mg/mL AmpicillincellWall

-0.394

Cephalexin20-100 ug/mL CephalexincellWall

0.151

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.837

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.863

EMB10-20 ug/mL EthambutolcellWall

-0.621

Eta12-40 ug/mL EthionamidecellWall

-0.604

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.532

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.447

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.988

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.957

BZA0.12 mg/mL BenzamidearomaticAmides

0.378

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.278

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.167

H2O24 mM hydrogen peroxideDNAdamaging

-0.285

Levo10 ug/mL LevofloxacinDNAdamaging

-0.374

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.404

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.727

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.302

UVUV-irradiationDNAdamaging

0.186

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.223

Antimycin12.5-50 ug/mL Antimycin A?

-1.153

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.329

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.215

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.429

PA8240.2-2 ug/mL PA-824?

0.604

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.132

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.138

Verapamil50 uM Verapamil?

-0.358

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.743

methoxatin10-20 ug/mL Methoxatin?